OTCMKTS:CDBT China Dasheng Biotechnology (CDBT) Stock Price, News & Analysis $0.06 0.00 (0.00%) As of 05/2/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartShort InterestBuy This Stock About China Dasheng Biotechnology Stock (OTCMKTS:CDBT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get CDBT alerts:Sign Up Key Stats Today's Range$0.06▼$0.0650-Day Range$0.03▼$0.0852-Week Range$0.00▼$0.08VolumeN/AAverage Volume11,973 shsMarket Capitalization$2.25 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewChina Dasheng Biotechnology Company, together with its subsidiaries, engages in the production, marketing, and distribution of bacteria based products used as additives for livestock feed and crop cultivation in the People's Republic of China. It provides artificial microorganisms (AM) and high-efficiency microorganism (HM) based biological bacterium blends; and biological preservatives. The company offers AM/HM bacteria based additives for crops, including Bulgaria lactobacillus, beer microzyme, and dark red spirilla used to increase the beneficial microorganism colonies in soil; inhibit the reproduction of harmful fungi and putrefactive bacteria; and to improve nutrient absorption and reduce crop and livestock diseases. It also provides AM/HM bacteria based additives for livestock feed, which softens the livestock feed and restrain the growth and reproduction of pathogenic bacteria, as well as supplies beneficial nutriments, including organic acid, vitamins, enzyme, antibiotics, mycelium protein, and other growth-enhancing substances that balance the nutrients in the feed. In addition, the company offers FGW bacterial based preservatives that preserve animal specimens for scientific research; and preserve the freshness for agricultural produce. Further, it provides bacteria based fertilizer for application on plants, such as vegetable and fruit leaves. Additionally, China Dasheng Biotechnology Company engages in residential and commercial real estate investment. The company was formerly known as Max Nutrition, Inc. and changed its name to China Dasheng Biotechnology Company in March 2008. China Dasheng Biotechnology Company was founded in 2004 and is based in Lanzhou, China.Read More… Receive CDBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for China Dasheng Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address CDBT Stock News HeadlinesChina Dasheng Biotechnology Co.: CDBT'S Transport Operations ExpandJune 5, 2023 | finanznachrichten.deCDBT'S Transport Operations ExpandJune 5, 2023 | finance.yahoo.comDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election … surpassing $100,000 on Dec. 8 .… Now Juan believes it could hit $150,000 … or higher in 2025.May 5, 2025 | Weiss Ratings (Ad)CDBT to acquire Cycclone Magnetic EnginesApril 24, 2023 | seekingalpha.comChina Dasheng Biotechnology Co.: CDBT Enters Agreement to Acquire Cycclone Magnetic Engines, Inc., the Founding Company of the Magnetic Engine ProjectApril 24, 2023 | finanznachrichten.deCycclone Magnetic Engines Acknowledges Embezzlement Allegations Against Cameron James Smith in their Transport HoldingsApril 20, 2023 | finance.yahoo.comChina Dasheng Biotechnology Company (CDBT)March 9, 2023 | finance.yahoo.comChina Dasheng Biotechnology Co.February 24, 2023 | barrons.comSee More Headlines CDBT Stock Analysis - Frequently Asked Questions How have CDBT shares performed this year? China Dasheng Biotechnology's stock was trading at $0.0610 at the start of the year. Since then, CDBT shares have decreased by 9.8% and is now trading at $0.0550. View the best growth stocks for 2025 here. How do I buy shares of China Dasheng Biotechnology? Shares of CDBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of China Dasheng Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some other companies that China Dasheng Biotechnology investors own include Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY), Global X Cloud Computing ETF (CLOU) and VelocityShares 1x Long VSTOXX Futures ETN (EVIX). Company Calendar Today5/05/2025Fiscal Year End6/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorBasic Materials Industry Drug stores & proprietary stores Sub-IndustryRetail Current SymbolOTCMKTS:CDBT CIKN/A WebN/A Phone(424) 358-1046Fax86-93-1844-1248Employees689Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares40,976,000Free FloatN/AMarket Cap$2.25 million OptionableNot Optionable Beta1.34 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (OTCMKTS:CDBT) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredU.S. Stock Market Now on Verge of CollapseThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China Dasheng Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share China Dasheng Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.